Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma

Cancer Immunology Immunotherapy

Volumn 44, Issue 1, 1997, Pages 48-54

  Sakurai, Takuma ^a   Yamada, Muneo ^a   Simamura, Seiichi ^a   Motoyoshi, Kazuo ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

B16 melanoma; M CSF; macrophage; NK 1.1

Indexed keywords

RECOMBINANT COLONY STIMULATING FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE; MALE; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; KILLER CELLS, NATURAL; LIVER; LIVER NEOPLASMS; LUNG; LUNG NEOPLASMS; MACROPHAGE-ACTIVATING FACTORS; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0030989826     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050354     Document Type: Article

References (37)

1. Balkwill FR (1989) Cytokines in cancer therapy. Oxford University Press, Oxford, pp 8-47
2. Balkwill FR (1989) Cytokines in cancer therapy. Oxford University Press, Oxford, pp 88-110
3. Bock SN, Cameron RB, Kragel P, Mule JJ, Rosenberg SA (1991) Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice. Cancer Res 51:2649-2654
4. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, et al (1993) Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223-1230
5. Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Lianes C, et al (1992) Natural killer (NK) cell stimulatory factor increase the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 175:789-796
6. 125I-5-iodo-2′-deoxyuridine 1,2,3. J Natl Cancer Inst 45:773-782
7. Fidler IJ (1973) The relationship of embolic homologeneity, number, size and viability to incidence of experimental metastasis. Eur J Cancer 9:223-227
8. Fidler IJ (1975) Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35:218-224
9. Hamuro J, Takatsuki F, Suga T, Kikuchu T, Suzuki M (1994) Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatments. Jpn J Cancer Res 85:1288-1297
10. Hanna N, Fidler IJ (1980) Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65:801-809
11. Hatake K, Motoyoshi K, Ishizaka Y, Takaku F, Miura Y (1985) Purification of human urinary colony-stimulating factor by high performance liquid chromatography. J Chromatogr 344:339-344
12. Hellstrand K, Asea A, Dahlgren C, Hermodesson S (1994) Histaminergic regulation of NK cells. J Immunol 153:4940-4947
13. Hume DA, Donahue RE, Fidler IJ (1989) The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res 8:69-77
14. Kurland JI, Pelus LM, Ralph P, Bockman RS, Moore MA (1979) Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci USA 76:2326-2330
15. Lasek W, Wankowicz A, Kuc K, Feleszko W, Golab J, Giermasz A, et al (1995) Potentiation of antitumor effects of tumor necrosis factor a and interferon γ by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice. Cancer Immunol Immunother 40:315-321
16. Li L, Xiao M, Wu B, Wang WX, Yan WR, Broxmeyer HE, et al (1993) In vivo effects of purified recombinant human macrophage colony-stimulating factor in comb ination with local hyperthermia on tumor progression in B16a melanoma bearing mice. Int J Hematol 58:139-152
17. Linnemeyer PA, Pollack SB (1993) Proslaglandin E2-induced change in the phenotype, morphology and lytic activity of IL-2-activated natural killer cells. J Immunol 150:3747-3754
18. Lu L, Shen RN, Zhou SZ, Wu B, Kim YJ, Lin ZH, et al (1991) Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the friend virus complex. Exp Hematol 19:804-809
19. Lu L, Xiao M, Wu B, Wang WX, Yan WR, Broxmeyer HE, et al (1993) In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice. Int J Hematol 58:139-152
20. Motoyoshi K, Takaku F (1989) Serum cholesterol-lowering activity of human monocytic colony-stimulating factor. Lancet II:326-327
21. Motoyoshi K, Yoshida K, Hatake K, Saito M, Miura Y, Yanai N, et al (1989) Recombinant and native human urinary colony-stimulating factor directly auguments granulocytic and granulocyte-macrophage colony-stimulating factor product ion of human peripheral blood monocytes. Exp Hematol 17:68-71
22. Nicolson GL, Winkelhake JL (1975) Organ specificity of blood-borne tumor metastasis determined by cell adhesion? Nature 255:230-232
23. Pollard JW, Hennighausen L (1994) Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci USA 91:9312-9316
24. Riccard C, Puccetti P, Santoni A, Herberman RB (1979) Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst 63:1041-1045
25. Sakurai T, Suzu S, Yamada M, Yanai N, Kawashima T, Hatake K, Takaku F, et al (1994) Induction of tumor necrosis factor in mice by recombinant human macrophage colony-stimulating factor. Jpn J Cancer Res 85:80-85
26. Steinhauer EH, Doyle AT, Reed J, Kadish AS (1982) Defective natural cytotoxicity in patient with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 129:2255-2259
27. Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, et al (1989) Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 49:5913-5917
28. Suzu S, Yanai N, Saito M, Kawashima T, Kasahara T, Saito M, et al (1990) Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor. Jpn J Cancer Res 81:79-84
29. Thomassen MJ, Barna BP, Wiedemann HP, Ahmad M (1990) Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor. J Biol Response Mod 9:87-91
30. Ulich TR, Castillo J, Watson LR, Yin S, Garnie MB (1990) In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood 75:846-850
31. Urano F, Imoto M, Fukuda Y, Koyama Y, Nakano I (1993) Effects of macrophage colony-stimulating factor on the proliferation and the function of kupffer cells. Arzneimittelforschung/Drug Res 43:804-807
32. Walsh P, Dorner A, Duke RC, Su LJ, Glode LM (1995) Macrophage colony-stimulating factor complimentary DNA: a candidate for gene therapy in metastatic melanoma. J Natl Cancer Inst 87:809-816
33. Warren MK, Ralph P (1986) Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, und colony stimulating activity. J Immunol 137:2281-2285
34. Weiner LM, Li W, Holmes M, Catalano RB, Dovanarsky M, Padavic K, et al (1994) Phase 1 trial of recombinant macrophage colony-stimulating factor and recombinant γ-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 54:4084-4090
35. William EC, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, et al (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395-1403
36. Wing EJ, Ampel NM, Waheed A, Shadduck RK (1985) Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 135:2052-2056
37. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-443